MA
Veradermics, Incorporated (MANE)
NYSE·Healthcare·Biotechnology
$99.73
+1.62%
Mkt Cap $4.12B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (4 analysts)
$162.67
Range $136.00 – $182.00
Implied Upside
+63.1%
Consensus $162.67 vs current $99.73
NYSE·Healthcare·Biotechnology
$99.73
+1.62%
Mkt Cap $4.12B
Buy
5
Hold
0
Sell
0
Price Target (4 analysts)
$162.67
Range $136.00 – $182.00
+63.1%
Consensus $162.67 vs current $99.73